PerioTrap Pharmaceuticals GmbH
PerioTrap Pharmaceuticals GmbH is a German biotech spin-off from Fraunhofer IZI that develops a patented selective pathoblocker technology targeting Porphyromonas gingivalis virulence to treat periodontitis, selling microbiome-friendly consumer toothpaste via DTC e-commerce and a professional prophylaxis gel to dental practices through Henry Schein distribution.
- Company typePrivate
- Founded2018
- HeadquartersHaale, Germany
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What PerioTrap Pharmaceuticals GmbH does
PerioTrap Pharmaceuticals GmbH is a German biopharmaceutical company founded in 2018 as a spin-off from the Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI), headquartered in Halle (Saale) at the Weinberg Campus technology park. The company develops a patented selective pathoblocker technology that targets the virulence mechanisms of periodontal pathogens — specifically Porphyromonas gingivalis via the small molecule S-0636 — without killing beneficial oral bacteria, thereby preserving the oral microbiome. This mechanistic approach is differentiated from conventional broad-spectrum antibacterial oral care products such as chlorhexidine, and is supported by multiple peer-reviewed publications and an endorsement from the German Society of Periodontology (DG PARO).
The company's commercial portfolio comprises two core products unified by the underlying PerioTrap® technology: a consumer-facing Mikrobiom Zahnpasta (microbiome toothpaste) priced at €14.95 per unit and sold direct-to-consumer via a Shopify e-commerce storefront, and a professional Prophylaxe Pflege-Gel (prophylaxis care gel) distributed to dental practices through Henry Schein and direct sales channels. A sonic toothbrush (Eco Vibe 3) is offered as a complementary accessory. The company serves two primary customer segments: health-conscious consumers seeking microbiome-friendly daily oral care, and dental professionals seeking adjunctive prophylaxis solutions for periodontal treatment.
PerioTrap employs a hybrid go-to-market model combining DTC e-commerce, B2B distribution via Henry Schein, and pharmacy/dental depot partnerships across Germany, Austria, and Switzerland. The company has raised approximately €5.8M cumulatively across seed (€200K, 2021), crowd-investing (€2.7M, 2025), and Pre-Series A first tranche (€2.9M, 2026) rounds. Operational team consists of fewer than 10 employees including microbiologists, pharmacists, and dentists. The microbiome toothpaste launch in 2026 achieved a complete sell-out within 12 hours of German media coverage, and the company is currently managing demand via a production waitlist while pursuing international expansion.
PerioTrap Pharmaceuticals GmbH firmographics
Firmographics- Name
- PerioTrap Pharmaceuticals GmbH
- Legal name
- PerioTrap Pharmaceuticals GmbH
- Website
- https://periotrap.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PerioTrap Pharmaceuticals GmbH is a German biotech spin-off from Fraunhofer IZI that develops a patented selective pathoblocker technology targeting Porphyromonas gingivalis virulence to treat periodontitis, selling microbiome-friendly consumer toothpaste via DTC e-commerce and a professional prophylaxis gel to dental practices through Henry Schein distribution.
- Ownership category
- akta.pro rank
PerioTrap Pharmaceuticals GmbH industry classification
Industry- Product category
- Oral Care Pharmaceuticals
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Toilet Preparation Manufacturing (325620)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Microbiome Modulating Small Molecules & Antibiotic Alternatives (HLAAAFAG)
- akta.pro secondary industry
- Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening) (CRADAMAA)
Keywords
Where PerioTrap Pharmaceuticals GmbH is headquartered
LocationHeadquarters
- HQ city
- Haale
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
PerioTrap Pharmaceuticals GmbH business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Consumer Oral Care Products: Direct-to-consumer sales of PerioTrap microbiome toothpaste (€14.95 per unit) through the company's Shopify e-commerce platform. Also sells sonic toothbrushes and other oral care accessories.
- Professional Dental Products: B2B sales of Prophylaxe Pflege-Gel (prophylaxis care gel) to dental practices through Henry Schein distribution network and direct sales to dental professionals for use in clinical settings.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | PerioTrap Mikrobiom Zahnpasta - Consumer toothpaste |
| Unit Pricing | Pay-as-you-go | Schallzahnbürste Eco Vibe 3 - Sonic toothbrush accessory |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
PerioTrap Pharmaceuticals GmbH product offering
Product offeringCore offering
PerioTrap develops and commercializes microbiome-friendly oral care products that selectively block the virulence mechanisms of pathogenic bacteria (notably Porphyromonas gingivalis) responsible for periodontitis while preserving the healthy oral microbiome. Its commercial portfolio includes a daily-use consumer toothpaste (Mikrobiom Zahnpasta) and a professional dental prophylaxis gel (Prophylaxe Pflege-Gel), both built on its patented PerioTrap® pathoblocker technology developed over more than 10 years at Fraunhofer IZI.
Product overview
PerioTrap Pharmaceuticals GmbH offers a dual-portfolio product strategy targeting both consumers and dental professionals, unified by the company's patented PerioTrap® technology. The consumer-facing portfolio centers on the PerioTrap® Mikrobiom Zahnpasta, a daily-use microbiome-friendly toothpaste that selectively blocks periodontal pathogens (notably Porphyromonas gingivalis) without damaging beneficial oral bacteria. The professional portfolio includes the PerioTrap® Prophylaxe Pflege-Gel, a dental-prophylaxis gel for use in clinical practice, complementing the consumer toothpaste as part of a system-care approach ("Systempflege: Professionell begleitet, präventiv gedacht"). Both products are grounded in over 10 years of research from the Fraunhofer IZI spin-off and are manufactured in Germany. The company also retails a sonic toothbrush (Eco Vibe 3) as a complementary accessory.
Differentiator
Problem solved
Functional benefit
Brands
- PerioTrap®: The company's core brand for oral microbiome-friendly dental care products including toothpaste and prophylaxis care gel.
Products and services
- PerioTrap® Mikrobiom Zahnpasta (Oral Microbiome Toothpaste) A microbiome-friendly toothpaste for daily home use that selectively blocks the virulence mechanisms of periodontal pathogens such as Porphyromonas gingivalis while preserving the healthy oral microbiome. Priced at €14.95 per unit (€19.93 per 100ml), sold direct-to-consumer and through professional channels.
- PerioTrap® Prophylaxe Pflege-Gel (Prophylaxis Care Gel) A prophylaxis care gel for professional dental use that supports tissue regeneration, soothes tissue, and complements periodontal prophylaxis treatment for patients with gingival or periodontal risk. Uses the same selective PerioTrap® technology as the consumer toothpaste. Distributed via Henry Schein and direct sales to dental professionals.
- Schallzahnbürste Eco Vibe 3 Set S (Sonic Toothbrush Eco Vibe 3) A sonic toothbrush sold as a bundled accessory set alongside PerioTrap oral care products, priced at €69.98 per set, marketed as a complement to daily oral hygiene routines for consumers.
Quantifiable outcome
- Reduces harmful biofilm mass by up to 25%
- +3 more outcomes
Companies that use PerioTrap Pharmaceuticals GmbH
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
PerioTrap Pharmaceuticals GmbH technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature3 records
PerioTrap Pharmaceuticals GmbH partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Fraunhofer IZIcoreFraunhofer Institute for Cell Therapy and Immunology, from which PerioTrap spun off. The company was founded based on research conducted at Fraunhofer IZI, with founding scientists continuing research relationships.
- Henry ScheincoreOne of the largest dental product distributors globally, now distributing PerioTrap Prophylaxe Pflege-Gel and Mikrobiom Zahnpasta to dental practices in Germany through their established procurement and ordering systems.
- EMS Dental DeutschlandminorPartner for the GBT Summit 2026 in Berlin, where PerioTrap exhibited alongside EMS Dental to promote modern prevention-oriented concepts and innovative solutions for successful dental practice management.
- Fly Fulfillment GmbHminorLogistics and fulfillment service provider handling warehousing and shipping of PerioTrap products, using JTL-Fulfillment Network for operational management. Delivers via DPD and DHL.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
PerioTrap Pharmaceuticals GmbH competitors and assessment
Company assessmentMarket position
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
PerioTrap Pharmaceuticals GmbH social profiles
Digital presencePerioTrap Pharmaceuticals GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
PerioTrap Pharmaceuticals GmbH leadership team
Management profileNumber of profiles
Profiles11 records
PerioTrap Pharmaceuticals GmbH funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PerioTrap Pharmaceuticals GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PerioTrap Pharmaceuticals GmbH
What does PerioTrap Pharmaceuticals GmbH do?
PerioTrap develops and commercializes microbiome-friendly oral care products that selectively block the virulence mechanisms of pathogenic bacteria (notably Porphyromonas gingivalis) responsible for periodontitis while preserving the healthy oral microbiome. Its commercial portfolio includes a daily-use consumer toothpaste (Mikrobiom Zahnpasta) and a professional dental prophylaxis gel (Prophylaxe Pflege-Gel), both built on its patented PerioTrap® pathoblocker technology developed over more than 10 years at Fraunhofer IZI.
Is PerioTrap Pharmaceuticals GmbH a public or private company?
PerioTrap Pharmaceuticals GmbH is a private company. It is classified as venture growth investor backed and is currently operating.
When was PerioTrap Pharmaceuticals GmbH founded?
PerioTrap Pharmaceuticals GmbH was founded in 2018. It employs 1 to 10 people.
Where is PerioTrap Pharmaceuticals GmbH based?
PerioTrap Pharmaceuticals GmbH is headquartered in Haale, Germany, in the Europe region.
How does PerioTrap Pharmaceuticals GmbH make money?
Two revenue lines are on record. Consumer Oral Care Products are the primary driver. The others are professional Dental Products.
Does PerioTrap Pharmaceuticals GmbH have an API?
No public API is recorded for PerioTrap Pharmaceuticals GmbH.
What industry is PerioTrap Pharmaceuticals GmbH in?
PerioTrap Pharmaceuticals GmbH's product category is Oral Care Pharmaceuticals. Its primary akta.pro industry code is HLAAAFAG, Microbiome Modulating Small Molecules & Antibiotic Alternatives, with a secondary code of CRADAMAA, Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening). Its NAICS code is 325414 and its SIC code is 2836.